drug protocol number

TVOC01

drug sponsor

Dilaforette AB

drug study

Sevuparin

drug trial site

King Khalid University Hospital (Riyadh), King Fahad Medical City (Riyadh), Qatif Central Hospital

drug status

Ongoing

drug phase